All The Most Important Pharmaceutical News Stories Of The Week – February 2018 – Week #3 US, EU, and Japan…
Tag Archive for "avelumab"
U.S. FDA Approves Pfizer’s Bosulif® (Bosutinib) For the Treatment of Patients with Newly-Diagnosed Ph+ Chronic Myelogenous Leukemia (CML) December 19,…
European Medicines Agency Validates Bristol-Myers Squibb’s Type II Variation Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) in Intermediate- and Poor-Risk…
Phase 3 Study Evaluating the Safety and Efficacy of Adjuvant Opdivo in Resected High-Risk Melanoma Patients Meets Primary Endpoint July 5, 2017…
AstraZeneca’s Imfinzi (durvalumab) receives US FDA accelerated approval for previously treated patients with advanced bladder cancer 01 May 2017 AstraZeneca…
March 23, 2017 The biopharma partners Merck KGaA and Pfizer came away with their first FDA approval of the…
February 28, 2017 EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. have announced that the…
New Research Details Published by Merck Scientists About the Early Development of Verubecestat November 2, 2016 Merck has announced the…
November 14, 2016 Pfizer Inc. has announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with…
AbbVie and Bristol-Myers Squibb Collaborate to Evaluate the Combination of Rova-T plus Opdivo and Opdivo + Yervoy Regimen July 25,…
October 31, 2016 KGaA, Darmstadt, Germany, and Pfizer Inc. have announced that the European Medicines Agency (EMA) has validated Marketing…